Baird Downgrades PAREXEL International (PRXL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
PAREXEL (PRXL) PT, Estimates Lowered at Evercore ISI
October 27, 2016 12:24 PM EDTEvercore ISI analyst Ross Muken lowered his price target on PAREXEL International (NASDAQ: PRXL) to $70.00 (from $79.00) but maintained a Buy rating following results.
The firm cut FY 2017 EPS from $4.05 to $3.75, FY 2018 EPS from $4.80 to $4.55 and FY 2019 EPS from $5.70 to $5.50.
Muken commented: ": This was not a pleasant quarter for anyone involved (unless you are short the stock) as most metrics missed and commentary on the remainder of 2017 did not inspire confidence.... More
Jefferies Cuts Price Target on Parexel (PRXL) to $67 Following Weak 1Q
October 27, 2016 9:33 AM EDTJefferies maintained a Hold rating on PAREXEL International (NASDAQ: PRXL), and cut the price target to $67.00 (from $72.50), following the company's 1Q earnings report. EPS fell 10c below consensus and guidance midpoint. PRXL's revenue shortfall accounted for ~4c. Updated guidance reduces revenue by... More
Parexel (PRXL) Misses Q1 EPS by 10c; Guides Below, Announces $200M Stock Buyback Plan
October 26, 2016 4:24 PM EDTParexel (NASDAQ: PRXL) reported Q1 EPS of $0.76, $0.10 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $0 versus the consensus estimate of $524.79 million.
Board approved new $200 million share repurchase program.
GUIDANCE:
Parexel sees... More
